CHRISTINE FARRELL
CIK 1200160 · Chief Financial Officer · last filed 2024-07-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
35
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIOJECT MEDICAL TECHNOLOGIES INC (BJCT) Delisted | VP of Finance | 87,722 | — | — | $0 | 15 | 2008-06-27 |
Recent Filings · Page 2 of 4
35 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-02-12 | — | Exer (M) | +25,000 | $0 | |
| 2010-01-04 | — | Exer (M) | +24,000 | $0 | |
| 2009-12-08 | — | Mixed | +5,000 | $0 | |
| 2009-03-10 | — | Exer (M) | +25,000 | $0 | |
| 2009-02-02 | — | Exer (M) | +75,000 | $0 | |
| 2009-01-20 | — | Exer (M) | +834 | $0 | |
| 2009-01-02 | — | Exer (M) | −24,000 | $0 | |
| 2009-01-02 | — | Exer (M) | +24,000 | $0 | |
| 2009-01-02 | — | Exer (M) | +24,000 | $0 | |
| 2008-12-10 | — | Exer (M) | +5,000 | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.